Completed NCT05333887
This summary needs review. Please check the official study record and contact the research team for details.
In Vancouver Why is this study shown? This study is directly about ADHD.
ADHD, Depression Behavioral Over 6 Years
Countries Canada
Sponsor University of British Columbia
Condition ADHD, Depression Completed NCT00254878
This study is completed in Germany. It focuses on ADHD.
In Freiburg im Breisgau Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 6 Years to 14 Years
Countries Germany
Sponsor Novartis
Condition ADHD Completed NCT01725737
This study is completed in Taiwan. It focuses on ADHD.
In Taipei Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries Taiwan
Sponsor Mackay Memorial Hospital
Condition ADHD Completed NCT00181714
This summary needs review. Please check the official study record and contact the research team for details.
In Cambridge Why is this study shown? This study is directly about ADHD.
ADHD Drug From 12 Years to 17 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition ADHD Completed NCT00723684
This summary needs review. Please check the official study record and contact the research team for details.
In Nijmegen Why is this study shown? This study is directly about ADHD.
ADHD Other From 8 Years to 15 Years
Countries Netherlands
Sponsor Radboud University Medical Center
Condition ADHD Completed NCT00593112
This summary needs review. Please check the official study record and contact the research team for details.
In Cambridge Why is this study shown? This study is directly about ADHD.
ADHD Drug From 12 Years to 18 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition ADHD Completed NCT00763971
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.
Multiple locations, including Hoboken Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 17 Years
Countries France, United Kingdom, Belgium, ...
Sponsor Shire
Condition ADHD Completed NCT00181857
This summary needs review. Please check the official study record and contact the research team for details.
In Boston Why is this study shown? This study is directly about ADHD.
ADHD Observational i A study where researchers collect information without assigning a treatment. Over 18 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition ADHD Completed NCT00253747
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Cambridge Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor University of Cincinnati
Condition ADHD Completed NCT00181948
This summary needs review. Please check the official study record and contact the research team for details.
In Cambridge Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 17 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition ADHD Completed NCT01939353
This study is completed in the United States. It is testing Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) for ADHD.
Multiple locations, including Bradenton Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Completed NCT03976570
This summary needs review. Please check the official study record and contact the research team for details.
In Erzurum Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 7 Years to 10 Years
Countries Türkiye
Sponsor Erzurum Regional Training & Research Hospital
Condition ADHD